SecBot SecBot
F-1 ·Filed Mar 2, 2026

NIVF

NewGenIvf Group Ltd
BEARISH
Impact 7/10
Horizonweeks Processed7mo ago SEC0001213900-26-022470
Foreign IPO registration
Actionable Insight ▼ Bearish

Traders should be cautious of the company's fundamental deterioration masked by one-time accounting gains. The stock may face downward pressure due to ongoing regulatory investigations, Nasdaq compliance risks, and the company's pivot into highly speculative ventures like cryptocurrency and real estate development. Monitor for any further regulatory actions in Hong Kong and Nasdaq compliance updates.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
NIVF ▼ -69.25% at T+60d
SHORT call ✓ call won +69.25% · α vs SPY +79.56% · entry $2.76 → $0.8500
Entry = T+0 close
Mar 2, 2026
via day close
T+1d
-4.49%
call +4.49% · α +5.25%
$2.64
settled 8mo ago
T+5d
-19.68%
call +19.68% · α +19.20%
$2.22
settled 8mo ago
T+20d
-18.23%
call +18.23% · α +13.83%
$2.26
settled 7mo ago
T+60d
-69.25%
call +69.25% · α +79.56%
$0.8500
settled 5mo ago

Executive Summary

NewGenIvf Group Ltd is an assisted reproductive services provider operating in Thailand, Cambodia, and Kyrgyzstan. The company is undergoing a significant business transformation, expanding into digital assets (Solana), real estate development in the UAE, and tokenization services. Financially, the company reported a net income of $17.4 million for the nine months ended September 30, 2025, driven by a non-cash bargain purchase gain, while revenue declined 20.6% year-over-year to $3.3 million. The company faces significant risks including Nasdaq listing compliance issues, regulatory scrutiny in Hong Kong regarding gender selection services, and substantial operational and financial risks associated with its new strategic initiatives.

Key Financial Metrics

Rev Growth
-20.6%

Key Facts

  • Company reported net income of $17.4 million for 9 months ended September 30, 2025, but this was driven by a non-cash $23.4 million bargain purchase gain, not operational performance
  • Revenue declined 20.6% year-over-year to $3.3 million for 9 months ended September 30, 2025, from $4.2 million in the prior period
  • Company is undergoing a significant strategic pivot into digital assets (Solana), UAE real estate, and tokenization services
  • Company faced Nasdaq delisting threats due to failure to meet minimum bid price, market value, and public float requirements
  • CEO and COO were arrested in Hong Kong for allegedly violating laws prohibiting commercial surrogacy arrangements and gender selection services
  • Company has substantial debt with convertible notes totaling $4.9 million outstanding as of September 30, 2025
  • Company has no insurance coverage for its operations and faces significant regulatory risks in multiple jurisdictions

Financial Impact

Revenue declined 20.6% to $3.3 million while net income of $17.4 million was driven by non-operational gains

revenuenet incomedebtcash flow

Risk Factors

  • Regulatory investigation in Hong Kong regarding gender selection and surrogacy services
  • Nasdaq listing compliance risks and potential delisting
  • Significant operational risks from diversification into cryptocurrency, real estate, and tokenization
  • Dependence on one-time accounting gains rather than sustainable revenue growth
  • Lack of insurance coverage exposing the company to substantial liability risks

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
F-1 Filing (Primary)0001213900-26-022470
Document: ea027917701ex10-36.htm0001213900-26-022470
22 reports for NIVF
Performance horizon
73% Hit rate @ T+1 8 of 11 directional calls Went positive at some point 9 of 11 best @ T+60▲ +88.71%Jul 1, 2026
Filters
Rows
Reports for NIVF — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
6-K
NEUTRAL ★ 4/10
$0.1884 $0.1489▼ −20.97%▼ −19.79%$1.15 (+510.40%)
Oct 7, 2026
18d ago
6-K
BEARISH ★ 7/10
$0.0811 $0.0721▲ +11.10%▲ +11.70%$1.15 (−1318.00%)
Oct 7, 2026
19d ago
6-K
NEUTRAL ★ 3/10
$0.1060 $0.0811▼ −23.49%▼ −23.07%$1.15 (+984.91%)
Oct 6, 2026
20d ago
SC 13D/A
NEUTRAL ★ 3/10
$0.0987 $0.1060▲ +7.40%▲ +7.64%$1.15 (+1065.15%)
Oct 5, 2026
21d ago
6-K
BEARISH ★ 6/10
$0.1100 $0.0987▲ +10.27%▲ +10.82%$1.15 (−945.45%)
Sep 30, 2026
26d ago
Press Release
BEARISH ★ 6/10
$0.1680 $0.1010▲ +39.88%▲ +40.06%$1.15 (−584.52%)
Sep 30, 2026
26d ago
424B4
BEARISH ★ 8/10
$5.38 $3.23▲ +39.88%▲ +40.06%$1.15 (+78.61%)
Sep 29, 2026
27d ago
EFFECT
BEARISH ★ 7/10
$0.0720 $0.1680▼ −133.33%▼ −133.54%$1.15 (−1497.22%)
Sep 28, 2026
27d ago
Press Release
BEARISH ★ 6/10
$0.0720 $0.1680▼ −133.33%▼ −133.54%$1.15 (−1497.22%)
Sep 2, 2026
7w ago
Insider Cluster
MIXED ★ 6/10
$1.21 $1.18▼ −2.48%▼ −3.53%$1.15 (−4.96%)
Showing 10 of 22

US Market Status

Market Closed — Opens Tue (17h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 2, 2026